These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 514424)

  • 41. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Problems of intravenous urography in patients with plasmocytoma].
    Gassmann W; Haferlach T; Schmitz N; Kayser W; Löffler H
    Schweiz Med Wochenschr; 1983 Feb; 113(8):301-4. PubMed ID: 6844902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Relationship between nonalcoholic fatty liver disease markers and renal function in patients with type 1 diabetes].
    Bulum T; Duvnjak L
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():6-10. PubMed ID: 23120807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
    Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ARF after retrograde pyelography: a case report and literature review.
    Chiu YS; Chiang HW; Huang CY; Tsai TJ
    Am J Kidney Dis; 2003 Aug; 42(2):E13-6. PubMed ID: 12900846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertension and nephrotoxicity in the rate of decline in kidney function in diabetic nephropathy.
    Aubia J; Hojman L; Chine M; Lloveras J; Masramon J; Llorach I; Cuevas X; Puig JM
    Clin Nephrol; 1987 Jan; 27(1):15-20. PubMed ID: 3815904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction.
    Amoah E; Glickman JL; Malchoff CD; Sturgill BC; Kaiser DL; Bolton WK
    Am J Nephrol; 1988; 8(3):204-11. PubMed ID: 3239594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.
    Keane WF; Brenner BM; de Zeeuw D; Grunfeld JP; McGill J; Mitch WE; Ribeiro AB; Shahinfar S; Simpson RL; Snapinn SM; Toto R;
    Kidney Int; 2003 Apr; 63(4):1499-507. PubMed ID: 12631367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How common is diabetic nephropathy?
    Daggett P
    Br J Hosp Med; 1986 Jan; 35(1):52-6. PubMed ID: 3754172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria.
    Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
    Nephrology (Carlton); 2013 Aug; 18(8):563-8. PubMed ID: 23714217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of reduced red blood cell deformability and diabetic nephropathy.
    Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA
    Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal function in adult Nigerian diabetics.
    Arije A; Akinsola W; Ladipo GO
    Trop Geogr Med; 1988 Oct; 40(4):334-7. PubMed ID: 3227554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.
    Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M
    Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
    Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
    Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention.
    Bachorzewska-Gajewska H; Malyszko J; Malyszko JS; Musial W; Dobrzycki S
    Nephrology (Carlton); 2006 Dec; 11(6):549-54. PubMed ID: 17199796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Random urine albumin:creatinine ratio measurements as a screening test for diabetic microalbuminuria--a five year follow up.
    Dunn PJ; Jury DR
    N Z Med J; 1990 Nov; 103(902):562-4. PubMed ID: 2243654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
    Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
    Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.